Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 3019410, 5 pages
http://dx.doi.org/10.1155/2016/3019410
Research Article

Impact of Iodinated Contrast on Renal Function and Hemodynamics in Rats with Chronic Hyperglycemia and Chronic Kidney Disease

1Experimentation Laboratory in Animal Model, School of Nursing, University of São Paulo, São Paulo, Brazil
2Department Medical-Surgical Nursing, School of Nursing, University of São Paulo, São Paulo, Brazil

Received 1 December 2015; Revised 26 January 2016; Accepted 4 February 2016

Academic Editor: Jeremiah R. Brown

Copyright © 2016 Sheila Marques Fernandes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. McCullough and S. S. Soman, “Contrast-induced nephropathy,” Critical Care Clinics, vol. 21, no. 2, pp. 261–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. A. McCullough, A. Adam, C. R. Becker et al., “Epidemiology and prognostic implications of contrast-induced nephropathy,” The American Journal of Cardiology, vol. 98, no. 6, supplement 1, pp. 5k–13k, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Rihal, S. C. Textor, D. E. Grill et al., “Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention,” Circulation, vol. 105, no. 19, pp. 2259–2264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Roy, V. Raya, T. Okabe et al., “Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels,” The American Journal of Cardiology, vol. 101, no. 11, pp. 1544–1549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Toprak, M. Cirit, M. Yesil et al., “Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 22, no. 3, pp. 819–826, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. N. Heyman, C. Rosenberger, S. Rosen, and M. Khamaisi, “Why is diabetes mellitus a risk factor for contrast-induced nephropathy?” BioMed Research International, vol. 2013, Article ID 123589, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Briguori, C. Quintavalle, E. Donnarumma, and G. Condorelli, “Novel biomarkers for contrast-induced acute kidney injury,” BioMed Research International, vol. 2014, Article ID 568738, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. C. Y. Wong, Z. Li, J. Guo, and A. Zhang, “Pathophysiology of contrast-induced nephropathy,” International Journal of Cardiology, vol. 158, no. 2, pp. 186–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Silver, P. M. Shah, G. M. Chertow, S. Harel, R. Wald, and Z. Harel, “Risk prediction models for contrast induced nephropathy: systematic review,” The British Medical Journal, vol. 351, Article ID h4395, 2015. View at Publisher · View at Google Scholar
  10. A. Caiazza, L. Russo, M. Sabbatini, and D. Russo, “Hemodynamic and tubular changes induced by contrast media,” BioMed Research International, vol. 2014, Article ID 578974, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. M. Schmidt-Ott, K. Mori, Y. L. Jau et al., “Dual action of neutrophil gelatinase-associated lipocalin,” Journal of the American Society of Nephrology, vol. 18, no. 2, pp. 407–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Whiter and F. E. Samson, “Determination of inulin in plasm and urine by use of antrone,” Journal of Laboratory and Clinical Medicine, vol. 43, no. 3, pp. 45–48, 1954. View at Google Scholar
  13. K. J. Berg, “Nephroltoxicity related to contrast media,” Scandinavian Journal of Urology, vol. 34, no. 5, pp. 317–322, 2000. View at Publisher · View at Google Scholar
  14. J. Ahmad, “Management of diabetic nephropathy: recent progress and future perspective,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 9, no. 4, pp. 343–358, 2015. View at Publisher · View at Google Scholar
  15. M. Kurdián, I. Herrero-Fresneda, N. Lloberas et al., “Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model,” PLoS ONE, vol. 7, no. 3, Article ID e32516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. C. de Resende, A. V. Pantoja, B. M. Barcellos et al., “Ischemic postconditioning and subanesthetic S(+)-ketamine infusion: effects on renal function and histology in rats,” BioMed Research International, vol. 2015, Article ID 864902, 8 pages, 2015. View at Publisher · View at Google Scholar
  17. C. D. Fonseca, M. Watanabe, M. H. Mendonca, S. M. Fernandes, and M. F. F. Vattimo, “Heme oxigenasse-1 as a potetial antioxidante agente for contrast induced nephropathy in diabetic rats,” Nephrology Dialysis Transplantation, vol. 29, supplement 3, pp. i63–i64, 2014. View at Google Scholar
  18. T.-Q. Liu, W.-L. Luo, X. Tan et al., “A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 427560, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Šochman, J. H. Peregrin, M. Bürgelová, L. Kopkan, H. J. Kramer, and L. Červenka, “N-acetylcysteine attenuates iodine contrast agent-induced nephropathy in 5/6-nephrectomized rats,” Kidney and Blood Pressure Research, vol. 33, no. 2, pp. 149–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Deedwania, M. Kosiborod, E. Barrett et al., “Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart association Diabetes Committee of the Council of Nutrition,” Circulation, vol. 117, no. 12, pp. 1610–1619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Russo, R. Minutolo, B. Cianciaruso, B. Memoli, G. Conte, and L. De Nicola, “Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure,” Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 1451–1458, 1995. View at Google Scholar · View at Scopus
  22. P. Persson, P. Hansell, and F. Palm, “Adenosine A2 receptor-mediated regulation of renal hemodynamics and glomerular filtration rate is abolished in diabetes,” Advances in Experimental Medicine and Biology, vol. 765, pp. 225–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. T. H. Hostetter, J. L. Troy, and B. M. Brenner, “Glomerular hemodynamics in experimental diabetes mellitus,” Kidney International, vol. 19, no. 3, pp. 410–415, 1981. View at Publisher · View at Google Scholar · View at Scopus
  24. S. N. Heyman, S. Rosen, and C. Rosenberger, “Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 1, pp. 288–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. N. Heyman, J. Reichman, and M. Brezis, “Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia,” Investigative Radiology, vol. 34, no. 11, pp. 685–691, 1999. View at Publisher · View at Google Scholar · View at Scopus